233 related articles for article (PubMed ID: 37009560)
1. Changes in Aqueous and Vitreous Inflammatory Cytokine Levels in Retinal Vein Occlusion: A Systematic Review and Meta-analysis.
Minaker SA; Mason RH; Bamakrid M; Lee Y; Muni RH
J Vitreoretin Dis; 2020; 4(1):36-64. PubMed ID: 37009560
[TBL] [Abstract][Full Text] [Related]
2. Differential analysis of aqueous humor cytokine levels in patients with macular edema secondary to diabetic retinopathy or retinal vein occlusion.
Hu KK; Tian CW; Li MH; Wu T; Gong M; Wei XL; Du YR; Hui YN; Du HJ
Int J Ophthalmol; 2023; 16(7):1041-1046. PubMed ID: 37465512
[TBL] [Abstract][Full Text] [Related]
3. The Changes of Irisin and Inflammatory Cytokines in the Age-Related Macular Degeneration and Retinal Vein Occlusion.
Li X; Cao X; Zhao M; Bao Y
Front Endocrinol (Lausanne); 2022; 13():861757. PubMed ID: 35370941
[TBL] [Abstract][Full Text] [Related]
4. Association of aqueous humor cytokines with the development of retinal ischemia and recurrent macular edema in retinal vein occlusion.
Jung SH; Kim KA; Sohn SW; Yang SJ
Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2290-6. PubMed ID: 24398091
[TBL] [Abstract][Full Text] [Related]
5. Changes in aqueous and vitreous inflammatory cytokine levels in diabetic macular oedema: a systematic review and meta-analysis.
Minaker SA; Mason RH; Lahaie Luna G; Farahvash A; Garg A; Bhambra N; Bapat P; Muni RH
Acta Ophthalmol; 2022 Feb; 100(1):e53-e70. PubMed ID: 33945678
[TBL] [Abstract][Full Text] [Related]
6. Changes in aqueous and vitreous inflammatory cytokine levels in neovascular age-related macular degeneration: a systematic review and meta-analysis.
Minaker SA; Mason RH; Lahaie Luna G; Bapat P; Muni RH
Acta Ophthalmol; 2021 Mar; 99(2):134-155. PubMed ID: 32602185
[TBL] [Abstract][Full Text] [Related]
7. Changes in aqueous and vitreous inflammatory cytokine levels in proliferative diabetic retinopathy: a systematic review and meta-analysis.
Mason RH; Minaker SA; Lahaie Luna G; Bapat P; Farahvash A; Garg A; Bhambra N; Muni RH
Eye (Lond); 2022 Jun; ():. PubMed ID: 35672457
[TBL] [Abstract][Full Text] [Related]
8. Emerging applications of bioinformatics and artificial intelligence in the analysis of biofluid markers involved in retinal occlusive diseases: a systematic review.
Pur DR; Krance S; Pucchio A; Bassi A; Miranda RN; Felfeli T
Graefes Arch Clin Exp Ophthalmol; 2023 Feb; 261(2):317-336. PubMed ID: 35925451
[TBL] [Abstract][Full Text] [Related]
9. The correlation between cytokine levels in the aqueous humor and the prognostic value of anti-vascular endothelial growth factor therapy for treating macular edema resulting from retinal vein occlusion.
Yong H; Qi H; Yan H; Wu Q; Zuo L
Graefes Arch Clin Exp Ophthalmol; 2021 Nov; 259(11):3243-3250. PubMed ID: 34059950
[TBL] [Abstract][Full Text] [Related]
10. Intraocular cytokines in retinal vein occlusion and its relation to the efficiency of anti-vascular endothelial growth factor therapy.
Shchuko AG; Zlobin IV; Iureva TN; Ostanin AA; Chernykh ER; Mikhalevich IM
Indian J Ophthalmol; 2015 Dec; 63(12):905-11. PubMed ID: 26862095
[TBL] [Abstract][Full Text] [Related]
11. Creation of Retinal Vein Occlusion Model in Cynomolgus Monkeys and Determination of its Pathological Features.
Inagaki S; Shimazawa M; Otsu W; Araki T; Numata Y; Nakamura S; Tsusaki H; Hara H
Curr Neurovasc Res; 2021; 18(1):123-133. PubMed ID: 32867658
[TBL] [Abstract][Full Text] [Related]
12. Effect of intravitreal dexamethasone implant on intra-ocular cytokines and chemokines in eyes with retinal vein occlusion.
Rezar-Dreindl S; Eibenberger K; Pollreisz A; Bühl W; Georgopoulos M; Krall C; Dunavölgyi R; Weigert G; Kroh ME; Schmidt-Erfurth U; Sacu S
Acta Ophthalmol; 2017 Mar; 95(2):e119-e127. PubMed ID: 27417275
[TBL] [Abstract][Full Text] [Related]
13. A Review of Intraocular Biomolecules in Retinal Vein Occlusion: Toward Potential Biomarkers for Companion Diagnostics.
Wang B; Zhang X; Chen H; Koh A; Zhao C; Chen Y
Front Pharmacol; 2022; 13():859951. PubMed ID: 35559255
[TBL] [Abstract][Full Text] [Related]
14. Comparison of cytokine levels from undiluted vitreous of untreated patients with retinal vein occlusion.
Koss MJ; Pfister M; Rothweiler F; Michaelis M; Cinatl J; Schubert R; Koch FH
Acta Ophthalmol; 2012 Mar; 90(2):e98-e103. PubMed ID: 22066978
[TBL] [Abstract][Full Text] [Related]
15. Stromal-derived factor-1 and inflammatory cytokines in retinal vein occlusion.
Ki-I Y; Arimura N; Noda Y; Yamakiri K; Doi N; Hashiguchi T; Maruyama I; Shimura M; Sakamoto T
Curr Eye Res; 2007 Dec; 32(12):1065-72. PubMed ID: 18085471
[TBL] [Abstract][Full Text] [Related]
16. Role of inflammation in previously untreated macular edema with branch retinal vein occlusion.
Noma H; Mimura T; Shimada K
BMC Ophthalmol; 2014 May; 14():67. PubMed ID: 24884703
[TBL] [Abstract][Full Text] [Related]
17. Role of soluble vascular endothelial growth factor receptors-1 and -2, their ligands, and other factors in branch retinal vein occlusion with macular edema.
Noma H; Mimura T; Yasuda K; Shimura M
Invest Ophthalmol Vis Sci; 2014 Jun; 55(6):3878-85. PubMed ID: 24894397
[TBL] [Abstract][Full Text] [Related]
18. Cytokine Kinetics after Monthly Intravitreal Bevacizumab for Retinal Vein Occlusion Associated with Macular Oedema.
Noma H; Mimura T; Yasuda K; Shimura M
Ophthalmic Res; 2016; 56(4):207-214. PubMed ID: 27160159
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of vitreous chemokines involved in ischemic retinal vein occlusion.
Zeng Y; Cao D; Yu H; Zhuang X; Yang D; Hu Y; He M; Zhang L
Mol Vis; 2019; 25():756-765. PubMed ID: 31814701
[TBL] [Abstract][Full Text] [Related]
20. Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion.
Suzuki Y; Nakazawa M; Suzuki K; Yamazaki H; Miyagawa Y
Jpn J Ophthalmol; 2011 May; 55(3):256-263. PubMed ID: 21538000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
